Zobrazeno 1 - 10
of 89
pro vyhledávání: '"John W. Ensinck"'
Autor:
David A. D'Alessio, Marcelo Rubinstein, Michael R. Stamm, Veronica Otero-Corchon, Jonathan D. Krakover, Robin E. Vogel, Ross C. Hoffman, Torsten P. Vahl, Bruce H. Francis, Denis G. Baskin, Ellen C. Laschansky, Malcolm J. Low, John W. Ensinck
Publikováno v:
Endocrinology. 143:2599-2609
Preprosomatostatin is a gene expressed ubiquitously among vertebrates, and at least two duplications of this gene have occurred during evolution. Somatostatin-28 (S-28) and somatostatin-14 (S-14), C-terminal products of prosomatostatin (ProS), are di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::323716a2d282953c23db8321eceb32cc
https://doi.org/10.1210/endo.143.7.8904
https://doi.org/10.1210/endo.143.7.8904
Autor:
Donna J. Koerker, John W. Ensinck, Robin E. Vogel, Ellen C. Laschansky, David A. D'Alessio, Ronald L. Prigeon, Steven E. Kahn
Publikováno v:
Journal of Clinical Investigation. 100:2295-2302
Somatostatin-28 (S-28), secreted into the circulation from enterocytes after food, and S-14, released mainly from gastric and pancreatic D cells and enteric neurons, inhibit peripheral cellular functions. We hypothesized that S-28 is a humoral regula
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fe0fd114a169899a04a15761b48120a
https://doi.org/10.1172/jci119767
https://doi.org/10.1172/jci119767
Autor:
Donna J. Koerker, Robin E. Vogel, John Eng, David A. D'Alessio, Ron L. Prigeon, John W. Ensinck, Ellen C. Laschansky
Publikováno v:
Journal of Clinical Investigation. 97:133-138
Glucagon-like peptide 1 (GLP-1) is an insulinotropic hormone released after nutrient ingestion which is known to augment insulin secretion, inhibit glucagon release, and promote insulin-independent glucose disposition. To determine the overall effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67b0b6e097726147535972e2ef6452d9
https://doi.org/10.1172/jci118380
https://doi.org/10.1172/jci118380
Autor:
Marian T. Childs, John W. Ensinck, Karen E. Friday, Edwin L. Bierman, Wilfred Y. Fujimoto, S Zambon
Publikováno v:
The American Journal of Clinical Nutrition. 56:447-454
Using a random crossover design, we examined the effects of glyburide for 4 wk on glucose, insulin, lipid, and lipoprotein metabolism in 10 men with non-insulin-dependent diabetes (NIDDM) receiving dietary fish-oil concentrates containing omega 3 (n-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa77eadba63b3d0c3006522ba73408fb
https://doi.org/10.1093/ajcn/56.2.447
https://doi.org/10.1093/ajcn/56.2.447
Autor:
Sandro Mossi, Christoph Eggenberger, Klaus Gyr, Pius Hildebrand, John W. Ensinck, Jörg D. Leuppi, Christoph Beglinger
Publikováno v:
Gastroenterology. 103:240-247
Somatostatin 28 (S-28), originating in gastrointestinal cells, is secreted into the circulation and increases in humans after ingestion of a mixed meal. To evaluate the possibility that the increased levels of S-28 post cibum might modulate the relea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f05905b2079573f53353eac91ac9ecb
https://doi.org/10.1016/0016-5085(92)91119-o
https://doi.org/10.1016/0016-5085(92)91119-o
Autor:
Rodger A. Liddle, John W. Ensinck
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 70:1403-1407
In man, plasma cholecystokinin (CCK) and somatostatin-28 (S-28) levels increase after ingestion of a mixed meal. Both peptides originate from the gastrointestinal tract. In supra- and periphysiological doses, CCK stimulates the release of somatostati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3a6ae1f72570724696a7e5d4c151cba
https://doi.org/10.1210/jcem-70-5-1403
https://doi.org/10.1210/jcem-70-5-1403
Publikováno v:
Diabetes. 44(12)
Glucagon-like peptide I (GLP-I)(7–36) amide is secreted by intestinal L-cells in response to food ingestion. GLP-I is a potent insulin secretagogue and also inhibits glucagon release. Inaddition, when given to humans in pharmacological amounts, GLP
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d585f804a5b9b238eeef12982408654
https://pubmed.ncbi.nlm.nih.gov/7589851
https://pubmed.ncbi.nlm.nih.gov/7589851
Publikováno v:
Scopus-Elsevier
Glucagon-like peptide 1 [7-36 amide] (GLP-1) has been shown to enhance insulin secretion in healthy and type II diabetic humans, and to increase glucose disposal in type I diabetic patients. To further define its action on glucose kinetics, we studie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36786673239c436664ae2bf878c8a85c
https://europepmc.org/articles/PMC294382/
https://europepmc.org/articles/PMC294382/
Autor:
Christoph Wollny, Manfred R. Von Der Ohe, Peter Layer, Harald Goebell, Christoph Beglingerv, Theo L. Peeters, John W. Ensinck
Publikováno v:
Gastroenterology. 103(3)
To determine the effects of small increases in somatostatin 28 plasma concentrations on human interdigestive gastrointestinal motility and pancreatic secretion, six fasting volunteers were intubated with gastroduodenal multilumen tubes and motility a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::235f06e3481789d7065a2e77485c2d7e
https://pubmed.ncbi.nlm.nih.gov/1379957
https://pubmed.ncbi.nlm.nih.gov/1379957